Incyte Corporation
INCY Healthcare Biotechnology
Incyte Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 21.2% from fiscal 2024. In the quarter to June 2026, revenue grew 37.7%, EPS grew 39.7%, free cash flow grew 1,829.5% and total debt fell 10.5%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years.
Follow INCY
Incyte Corporation (INCY) Gross margin
Incyte Corporation's gross margin over the twelve months to 30 June 2026 was 92.6%, down 0.1 percentage points from fiscal 2025 (92.8%). Over the past ten years it has ranged from 92.6% (fiscal 2024) to 96.4% (fiscal 2015); the current reading is higher than 18% of that period. That is above the Biotechnology industry median of 65.8% and above the Healthcare sector median of 54.1%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 92.8% | 0.12 |
| FY2024 | 92.6% | (0.46) |
| FY2023 | 93.1% | (0.80) |
| FY2022 | 93.9% | (1.04) |
| FY2021 | 94.9% | (0.14) |
| FY2020 | 95.1% | 0.37 |
| FY2019 | 94.7% | (0.29) |
| FY2018 | 95.0% | 0.17 |
| FY2017 | 94.8% | 0.09 |
| FY2016 | 94.7% | (1.68) |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Jun 2026 | 93.7% | 1.94 |
| Mar 2026 | 91.8% | (0.17) |
| Dec 2025 | 92.0% | (0.79) |
| Sep 2025 | 92.8% | (0.77) |
| 42 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| RPRX Royalty Pharma PLC compare | 100.0% |
| EXEL Exelixis, Inc. compare | 96.5% |
| GMAB Genmab A/S Sponsored ADR compare | 93.0% |
| INCY Incyte Corporation | 92.6% |
| ASND Ascendis Pharma A/S compare | 91.3% |
| INSM Insmed, Inc. compare | 83.5% |
| ROIV Roivant Sciences Ltd. compare | 81.2% |
| ALNY Alnylam Pharmaceuticals, Inc. compare | 79.7% |
| BNTX BioNTech SE Sponsored ADR compare | 75.2% |
| Biotechnology industry median | 65.8% |
| Healthcare sector median | 54.1% |
| Market median | 46.2% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on INCY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement